Literature DB >> 15518622

Relation of calcium-phosphorus product to the severity of aortic stenosis in patients with normal renal function.

William R Mills1, Douglas Einstadter, Robert S Finkelhor.   

Abstract

Calcium-phosphorus product (CaxP) has been associated with severity of aortic stenosis (AS) in dialysis patients, but it is unknown whether a relation exists in patients with normal renal function. One hundred seven patients with AS and normal serum creatinine were studied to determine whether there was an association between CaxP and AS severity, and it was found that CaxP was inversely related to AS severity, as measured by aortic valve area and transvalvular gradients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15518622     DOI: 10.1016/j.amjcard.2004.07.095

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.

Authors:  Ashvin R Kamath; Ramdas G Pai
Journal:  Int J Angiol       Date:  2008

2.  Calcium and phosphate concentrations and future development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study.

Authors:  Carlos Lorenzo; Anthony J Hanley; Marian J Rewers; Steven M Haffner
Journal:  Diabetologia       Date:  2014-04-26       Impact factor: 10.122

3.  Association of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study.

Authors:  Jason P Linefsky; Kevin D O'Brien; Ronit Katz; Ian H de Boer; Eddy Barasch; Nancy S Jenny; David S Siscovick; Bryan Kestenbaum
Journal:  J Am Coll Cardiol       Date:  2011-07-12       Impact factor: 24.094

4.  Mineral metabolism disturbances are associated with the presence and severity of calcific aortic valve disease.

Authors:  Zhen-kun Yang; Chen Ying; Hong-yan Zhao; Yue-hua Fang; Ying Chen; Wei-feng Shen
Journal:  J Zhejiang Univ Sci B       Date:  2015-05       Impact factor: 3.066

Review 5.  Insights into the use of biomarkers in calcific aortic valve disease.

Authors:  Erik Beckmann; Juan B Grau; Rachana Sainger; Paolo Poggio; Giovanni Ferrari
Journal:  J Heart Valve Dis       Date:  2010-07

6.  Alendronate slows down aortic stenosis progression in osteoporotic patients: An observational prospective study.

Authors:  Gholamhossein Alishiri; Kiyan Heshmat-Ghahdarijani; Mohammad Hashemi; Reihaneh Zavar; Maryam Moshkani Farahani
Journal:  J Res Med Sci       Date:  2020-06-30       Impact factor: 1.852

7.  Relationship between Calcium-Phosphorus Product and Severity of Valvular Heart Insufficiency in Patients Undergoing Chronic Hemodialysis.

Authors:  Masoumeh Kahnooj; Mohammad Masoomi; Ali Naderinasab; Akram Zaeem; Mehrdad Sheikhvatan
Journal:  J Tehran Heart Cent       Date:  2010-05-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.